The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMast Energy. Regulatory News (MAST)

Share Price Information for Mast Energy. (MAST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.195
Bid: 0.19
Ask: 0.20
Change: 0.00 (0.00%)
Spread: 0.01 (5.263%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.195
MAST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Board Appointment

1 Oct 2021 07:00

RNS Number : 6474N
Mast Energy Developments PLC
01 October 2021
 

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

("MED" or "the Company")

 

1 October 2021

 

Mast Energy Developments Plc ("MED" or "the Company")

 

New Board Appointment

 

Mast Energy Developments Plc (MED), the UK-based multi-asset operator in the rapidly growing Reserve Power market and currently with c. 20 MW gas peaker sites under its direct control and development, is pleased to announce that it has appointed Mr Dominic Traynor as non-executive director to the Board of Directors with effect from 1 October 2021.

· Mr Traynor is a London based company director and solicitor specializing in equity capital markets, and partner at Druces LLP, one of the City's oldest law firms. He specializes in corporate law, listings and takeovers, M&A and corporate finance. He advised on the structuring and listing of more than 30 companies on the Main Market and Alternative Investment Market (AIM) of the London stock exchange. Dominic graduated from the College of Law, York, and received his LLB from Durham University.

· Concurrent with this new appointment MED advises that Mrs Candice Theron is stepping down from the BOD effectively 30 September 2021 to pursue fulltime business interests.

The following information relating to Mr Traynor:

Directorships in public companies in last five years

· EV Metals Group plc (alternate)

· Raven Resources plc

· IT Infinite Technologies plc

Former public company appointments in last five years:

· SigmaRoc plc

· Neptune Mineral Investments plc

· Wildcat Mining & Exploration plc

Save as disclosed there are no other matters to be disclosed under Listing Rule 9.6.13 R

 

Louis Coetzee, Non-Executive Chairman said: "We are delighted with Dominic joining MED's Board of Directors. He is a seasoned professional and brings a wealth of experience that can be focused on the successful roll out of MED's strategy to have 300 MW generating capacity on the ground.

MED, also at this time, expresses it sincere appreciation to Mrs Theron for her enthusiasm, energetic approach and value-added contributions prior to and post MED's listing to successfully roll out the first c. 20 MW of generating capacity and we wish her well in the pursuit of her new endeavours.

Further information on the Company, including the prospectus published in conjunction with Admission, can be found on the Company's website: www.med.energy

 

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR"). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

ENDS

 

For further information please visit www.med.energy or contact:

 

Louis Coetzee

info@med.energy

Mast Energy Developments plc

Non-Executive Chairman

Jonathan Critchley &

Keith Swann

+44 (0)20 3869 6080

Clear Capital Markets

Joint Broker

Chris Hardie & Sarah Mather

+44 (0)20 7220 1666

WH Ireland Ltd

Joint Broker

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAURORRARUKOUR
Date   Source Headline
23rd May 20243:55 pmRNSCapitalisation of Loan Update
21st May 20247:00 amRNSBusiness Update
9th May 202410:45 amRNSHolding(s) in Company
8th May 20247:00 amRNSNotice of AGM
7th May 20247:00 amRNSUpdate, Loan Capitalisation & Equity Issue
30th Apr 20247:00 amRNSResults for the year ended 31 December 2023
26th Apr 20247:00 amRNSBusiness Update
23rd Apr 20242:30 pmRNSHolding(s) in Company TR 1
11th Apr 20247:00 amRNSBusiness Update
7th Mar 20248:06 amRNSQ1 2024 Corporate Presentation
4th Mar 202410:45 amRNSHolding(s) in Company
28th Feb 20247:00 amRNSFunding Partner, Agreement & Proventure Terminated
20th Feb 20241:00 pmRNSTR-1: Standard form notification of major holdings
5th Feb 20241:55 pmRNSTR-1: Standard form notification of major holdings
24th Jan 20243:45 pmRNSHolding(s) in Company
8th Jan 20247:00 amRNSMED Binding JVA Progress Update
2nd Jan 20247:00 amRNSMED Binding JVA Completion Update
22nd Dec 20237:00 amRNSMED Binding JVA Completion Update
15th Dec 20237:00 amRNSDirector Loan & PDMR Share Sale
11th Dec 20237:52 amRNSMED Binding JVA Update
11th Dec 20237:00 amRNSMED Binding JVA Completion Update
5th Dec 20234:30 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSMED Binding JVA Completion Update
15th Nov 20233:31 pmRNSDirector/PDMR Shareholding
13th Nov 20237:00 amRNSMED Binding JVA Interim Payment Update
26th Oct 202310:54 amRNSHolding(s) in Company
23rd Oct 20237:00 amRNSMED Binding JVA Completion Update
12th Oct 20232:03 pmRNSHolding(s) in Company
12th Oct 20232:01 pmRNSHolding(s) in Company
12th Oct 20232:00 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSIssue of Equity
22nd Sep 20237:00 amRNSMED Binding JVA Completion Update
1st Sep 20237:00 amRNSMED Binding Joint Venture Completion Update
25th Aug 20237:00 amRNSHalf-year Report
9th Aug 20232:16 pmRNSHolding(s) in Company
4th Aug 20237:00 amRNSMED Binding Joint Venture Completion Update
12th Jul 20231:15 pmRNSJoint Venture
6th Jun 20231:09 pmRNSResult of AGM
23rd May 20232:30 pmRNSIssue of Equity
22nd May 20233:00 pmRNSShares issue
18th May 20237:00 amRNSJV & Investment. New Broker & Loan Reprofiling
16th May 20231:15 pmRNSNotice of AGM
4th May 20237:00 amRNSQ1 Corporate Presentation and Website Update
28th Apr 20237:00 amRNSResults for the year ended 31 December 2022
27th Feb 20237:00 amRNSPyebridge Update
20th Dec 20224:40 pmRNSSecond Price Monitoring Extn
20th Dec 20224:35 pmRNSPrice Monitoring Extension
20th Dec 20222:05 pmRNSSecond Price Monitoring Extn
20th Dec 20222:00 pmRNSPrice Monitoring Extension
16th Dec 20227:00 amRNSPyebridge SPA Deferred Consideration Settlement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.